4/A//SEC Filing
Rombotis Spiro George 4/A
Accession 0001104659-21-150527
CIK 0001130166other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 4:16 PM ET
Size
6.2 KB
Accession
0001104659-21-150527
Insider Transaction Report
Form 4/AAmended
Rombotis Spiro George
DirectorPresident & C.E.O.
Transactions
- Award
Stock Option (right to buy)
2021-12-13+190,000→ 190,000 totalExercise: $3.45Exp: 2031-12-13→ Common Stock (190,000 underlying)
Footnotes (3)
- [F1]These securities are exercisable over a three-year period, with 1/36 of the options granted vesting on a monthly basis.
- [F2]These securities were granted as part of the Issuer's annual compensation review to executive officers.
- [F3]This Form 4 is being amended to correct a typographical error in the number of shares of Common Stock underlying the options granted to the reporting person on December 13, 2021. 190,000 shares of Common Stock underlie the granted options.
Documents
Issuer
Cyclacel Pharmaceuticals, Inc.
CIK 0001130166
Entity typeother
Related Parties
1- filerCIK 0001357396
Filing Metadata
- Form type
- 4/A
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 4:16 PM ET
- Size
- 6.2 KB